---
figid: PMC3190726__zbc0331170190011
figlink: /pmc/articles/PMC3190726/figure/F11/
number: FIGURE 11
caption: Schematic representation of the dual ERK1-dependent impact on regulated processing
  and transcription of PrPc. Stimulation of M1/M3 muscarinic receptors triggers PKC-dependent
  activation of the MEK/ERK signaling pathway. Activated ERK1 then 1) directly phosphorylates
  ADAM17 on its intracytoplasmic threonine residue at position 735, thereby increasing
  ADAM17 activity, the processing of PrPc at the 111/112 peptidyl bond, and the secretion
  of the neuroprotective N1 fragment; 2) increases PrPc promoter transactivation and
  mRNA levels in an AP1-dependent manner. Mutational analysis indicates that AP-1
  directly activates PrPc transcription likely after formation of well documented
  ERK-1-dependent build-up with phosphorylation of c-Fos and its subsequent association
  with phospho-c-Jun (). Therefore, under physiological conditions, ERK1 participates
  via two distinct processes (elevation of both substrate levels and enzyme activity)
  to an overall increase of the N1-associated neuroprotective phenotype.
pmcid: PMC3190726
papertitle: The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated α-Secretase-mediated
  Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein.
reftext: Moustapha Cissé, et al. J Biol Chem. 2011 Aug 19;286(33):29192-29206.
pmc_ranked_result_index: '141888'
pathway_score: 0.9569746
filename: zbc0331170190011.jpg
figtitle: The dual ERK1-dependent impact on regulated processing and transcription
  of PrPc
year: '2011'
organisms: Homo sapiens
ndex: caa51456-dee3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3190726__zbc0331170190011.html
  '@type': Dataset
  description: Schematic representation of the dual ERK1-dependent impact on regulated
    processing and transcription of PrPc. Stimulation of M1/M3 muscarinic receptors
    triggers PKC-dependent activation of the MEK/ERK signaling pathway. Activated
    ERK1 then 1) directly phosphorylates ADAM17 on its intracytoplasmic threonine
    residue at position 735, thereby increasing ADAM17 activity, the processing of
    PrPc at the 111/112 peptidyl bond, and the secretion of the neuroprotective N1
    fragment; 2) increases PrPc promoter transactivation and mRNA levels in an AP1-dependent
    manner. Mutational analysis indicates that AP-1 directly activates PrPc transcription
    likely after formation of well documented ERK-1-dependent build-up with phosphorylation
    of c-Fos and its subsequent association with phospho-c-Jun (). Therefore, under
    physiological conditions, ERK1 participates via two distinct processes (elevation
    of both substrate levels and enzyme activity) to an overall increase of the N1-associated
    neuroprotective phenotype.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - C1R
  - PRKCI
  - FGFR3
  - PRKCH
  - C1QC
  - C1QA
  - PRKCZ
  - MAPK3
  - PRKD3
  - FOS
  - FOSL1
  - JUN
  - C1QB
  - JUND
  - PRKCQ
  - PRKCB
  - C1S
  - JUNB
  - PRKCG
  - PRKCA
  - ADAM17
  - PRKCD
  - PRKCE
  - FOSL2
  - RAF1
  - FOSB
  - Atropine
  - Carbachol
  - Cancer
genes:
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1R
  entrez: '715'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QC
  entrez: '714'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QA
  entrez: '712'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: '"+c-fos"""'
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: c-jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QB
  entrez: '713'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1S
  entrez: '716'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: ADAM17
  symbol: ADAM17
  source: hgnc_symbol
  hgnc_symbol: ADAM17
  entrez: '6868'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
chemicals:
- word: Atropine
  source: MESH
  identifier: D001285
- word: Carbachol
  source: MESH
  identifier: D002217
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
